Literature DB >> 25504324

Loneliness in the elderly is associated with the use of psychotropic drugs.

Friederike Boehlen1, Wolfgang Herzog1, Renate Quinzler2, Walter E Haefeli2, Imad Maatouk1, Dorothea Niehoff1, Kai-Uwe Saum3, Hermann Brenner4, Beate Wild1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the association between loneliness in elderly people with the use of psychotropic drugs.
METHODS: A subsample of 3111 participants (ages 55-85) of the large population-based German ESTHER study was included in the study. Loneliness was measured by using a three-item questionnaire. Two subgroups were defined according to their degrees of loneliness. Psychotropic drugs were categorized by study doctors. Logistic regression analyses were conducted to determine the association between loneliness subgroups and the use of psychotropic drugs adjusted for psychosocial variables, multimorbidity, depression, anxiety, and somatic symptom severity.
RESULTS: Of the participants 14.1% (95%-CI = [12.9; 15.4]) were estimated to have a high degree of loneliness (women > men); 19% (95%-CI = [17.6; 20.4]) of the participants used psychotropic drugs, 8.4% (95%-CI = [7.5; 9.5]) antidepressants. Logistic regression analysis showed that more lonely participants had significantly higher odds for using psychotropic drugs (OR: 1.495; 95%-CI = [1.121; 1.993]). Depression severity, somatic symptom severity, and female gender were also positively associated with the use of psychotropic drugs.
CONCLUSION: A high degree of subjective loneliness in the elderly is associated with the use of psychotropic drugs, even after adjustment for somatic and psychological comorbidities and psychosocial variables.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  age; loneliness; psychotropic drugs

Mesh:

Substances:

Year:  2014        PMID: 25504324     DOI: 10.1002/gps.4246

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

1.  Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.

Authors:  Courtney A Polenick; Brandi Parker Cotton; William C Bryson; Kira S Birditt
Journal:  Subst Use Misuse       Date:  2019-06-24       Impact factor: 2.164

2.  "Where are all the lonely people?" A population-based study of high-risk groups across the life span.

Authors:  Mathias Lasgaard; Karina Friis; Mark Shevlin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-08-29       Impact factor: 4.328

3.  Social Network and Risk of Poor Sleep Outcomes in Older Adults: Results from a Spanish Prospective Cohort Study.

Authors:  Rocio Leon-Gonzalez; Fernando Rodriguez-Artalejo; Rosario Ortola; Esther Lopez-Garcia; Esther Garcia-Esquinas
Journal:  Nat Sci Sleep       Date:  2021-03-17

4.  Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans.

Authors:  Tibor V Varga; Feifei Bu; Agnete S Dissing; Leonie K Elsenburg; Joel J Herranz Bustamante; Joane Matta; Sander K R van Zon; Sandra Brouwer; Ute Bültmann; Daisy Fancourt; Klaus Hoeyer; Marcel Goldberg; Maria Melchior; Katrine Strandberg-Larsen; Marie Zins; Amy Clotworthy; Naja H Rod
Journal:  Lancet Reg Health Eur       Date:  2021-03

5.  En route to flourishing - a longitudinal mixed methods study of long-term unemployed citizens in an interdisciplinary rehabilitation program.

Authors:  Lotte Nygaard Andersen; Mette Jensen Stochkendahl; Kirsten K Roessler
Journal:  BMC Public Health       Date:  2022-04-07       Impact factor: 3.295

6.  Psychological Distress, Loneliness, and Boredom Among the General Population of Tyrol, Austria During the COVID-19 Pandemic.

Authors:  Franziska Tutzer; Beatrice Frajo-Apor; Silvia Pardeller; Barbara Plattner; Anna Chernova; Christian Haring; Bernhard Holzner; Georg Kemmler; Josef Marksteiner; Carl Miller; Martin Schmidt; Barbara Sperner-Unterweger; Alex Hofer
Journal:  Front Psychiatry       Date:  2021-06-10       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.